MODIFIED RELEASE FORMULATIONS OF (6R)-4,5,6,7-TETRAHYDRO-N6-PROPYL-2,6-BENZOTHIAZOLE-DIAMINE AND METHODS OF USING THE SAME

摘要

Modified release pharmaceutical compositions (controlled release, sustained release, and/or extended release,) of R-pramipexole and methods of using such compositions for the treatment of neurodegenerative diseases, or those related to mitochondrial dysfunction or increased oxidative stress are disclosed.